TFA
ABBV icon

Teamwork Financial Advisors’s AbbVie ABBV Stock Holding History

Teamwork Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$505K Buy
2,009
+37
+2% +$7.96K 0.05% 128
2026
Q1 		$429K Buy
1,972
+9
+0.5% +$2K 0.05% 148
2025
Q4 		$448K Sell
1,963
-579
-23% -$132K 0.05% 139
2025
Q3 		$588K Sell
2,542
-666
-21% -$136K 0.06% 128
2025
Q2 		$595K Sell
3,208
-50,231
-94% -$9.34M 0.07% 118
2025
Q1 		$11.2M Buy
53,439
+50,966
+2,061% +$9.91M 1.49% 24
2024
Q4 		$439K Buy
2,473
+7
+0.3% +$1.29K 0.06% 117
2024
Q3 		$487K Sell
2,466
-452
-15% -$84.4K 0.07% 105
2024
Q2 		$500K Sell
2,918
-3,614
-55% -$599K 0.07% 89
2024
Q1 		$1.19M Sell
6,532
-1,119
-15% -$193K 0.18% 67
2023
Q4 		$1.19M Sell
7,651
-577
-7% -$84.1K 0.2% 59
2023
Q3 		$1.23M Buy
8,228
+22
+0.3% +$3.23K 0.2% 71
2023
Q2 		$1.11M Sell
8,206
-2,898
-26% -$425K 0.18% 79
2023
Q1 		$1.77M Sell
11,104
-439
-4% -$67.1K 0.33% 52
2022
Q4 		$1.87M Sell
11,543
-1,578
-12% -$242K 0.38% 44
2022
Q3 		$1.76M Sell
13,121
-1,218
-8% -$175K 0.38% 42
2022
Q2 		$2.2M Sell
14,339
-9,806
-41% -$1.5M 0.48% 45
2022
Q1 		$3.91M Sell
24,145
-5,225
-18% -$759K 0.73% 22
2021
Q4 		$3.98M Sell
29,370
-950
-3% -$112K 0.73% 20
2021
Q3 		$3.27M Buy
30,320
+5,294
+21% +$605K 0.65% 25
2021
Q2 		$2.82M Buy
25,026
+39
+0.2% +$4.39K 0.58% 31
2021
Q1 		$2.7M Sell
24,987
-1,710
-6% -$183K 0.63% 28
2020
Q4 		$2.86M Sell
26,697
-1,455
-5% -$140K 0.68% 22
2020
Q3 		$2.47M Sell
28,152
-7,273
-21% -$685K 0.76% 16
2020
Q2 		$3.48M Buy
35,425
+6,195
+21% +$545K 1.25% 14
2020
Q1 		$2.23M Buy
29,230
+2,430
+9% +$207K 1.38% 14
2019
Q4 		$2.37M Buy
+26,800
New +$2.22M 1.42% 15

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Teamwork Financial Advisors's ABBV Position: Q2 2026 in Review

Teamwork Financial Advisors increased its AbbVie (ABBV) stake by 1.9% in Q2 2026, buying an estimated $7.96K and bringing the position to 2,009 shares worth $505K. The position accounts for 0.05% of the portfolio, ranked #128.

Teamwork Financial Advisors first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $11.2M in Q1 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Teamwork Financial Advisors held 2,009 shares of AbbVie worth $505K as of Q2 2026.
  • Teamwork Financial Advisors bought 37 AbbVie shares in Q2 2026, an estimated $7.96K.
  • AbbVie made up 0.05% of Teamwork Financial Advisors's portfolio in Q2 2026, its #128 holding.
  • Teamwork Financial Advisors first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • Teamwork Financial Advisors's AbbVie position peaked at $11.2M in Q1 2025.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Teamwork Financial Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.